Lumenis At-A-Glance:

• Formed through the merger of ESC Medical Systems and Coherent Medical Group
• Global leader in medical lasers and light-based technology
• Sales presence in more than 100 countries worldwide, with direct sales in the major markets
• Leader in each of its markets—aesthetic, ophthalmic, surgical
• World’s largest installed base: more than 70,000 systems
• Holds 250 patents
• More than 900 direct employees
• Pioneered the use of lasers since 1966

Our Mission

Lumenis commits substantial resources to research and development. This investment in scientific and technological innovation is significant not only in its size and scope, but also in its focus: Enhancing Life. Advancing Technology.

Core Businesses and Products

Lumenis' business includes a diverse product portfolio comprised of aesthetic, ophthalmic, and surgical, as well as world class customer service support.

Lumenis Fiscal Year 2007

Scope of Applications

From doctors' offices and hospitals to medical spas, Lumenis products provide leading-edge solutions for a wide range of conditions, and include applications for the following markets:

Aesthetics

At Lumenis, we constantly push the boundaries of laser aesthetics. In fact, Lumenis holds more patents and has proven the effectiveness of our products in more clinical studies than any other aesthetic technology company in the world. Our products remove hair; eliminate facial blemishes, large vessels and spider veins; treat fine lines and wrinkles. The company pioneered IPL technology and photorejuvenation, an in-office procedure that reduces redness, age spots and fine lines with no patient downtime. We also introduced Lumenis One, the world’s only fourth-generation IPL system, featuring Optimal Pulse Technology. In 2005, Lumenis launched the Aluma Skin Renewal System, for non-invasive and virtually painless treatment of fine lines and wrinkles with predictable outcomes. These innovations demonstrate our continued commitment to provide our customers with revolutionary tools that help reveal the true beauty that dwells within. Lumenis is pleased to offer a continuum of solutions to meet the needs of aesthetic patients worldwide, with products that include: Lumenis One, LightSheer, Aluma, UltraPulse Encore, IPL Quantum and Elora.

Ophthalmic

First then. First now. Since introducing the first laser photocoagulator to ophthalmology in 1970, Lumenis has focused on providing ophthalmologists innovative laser therapies to preserve and improve the sight of patients worldwide. Attentive to trends in Ophthalmology for early intervention, therapies developed by Lumenis are safe, selective and minimally invasive. Our laser systems, including the highly regarded Novus Varia and Selecta II, treat sight-threatening diseases such as diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), and secondary cataracts. Today, Lumenis offers the most complete line of ophthalmic laser solutions in the industry used from the office, clinic and surgery center to the operating room, for treating conditions in the front of the eye to the back, and designed to improve and preserve sight from infancy to old age.

Surgical

Driven by a passion to serve its surgical customers and their patients, Lumenis is leading the way to a healthier tomorrow. Lumenis offers the most sophisticated laser technology, such as our flagship VersaPulse and UltraPulse lasers—to urology, otolaryngology, gynecology and orthopedic surgeons, as well as physicians in many other specialties. The versatility of Lumenis' product portfolio and clinical applications enable physicians to treat a growing number of medical conditions, whether based in an office or the hospital.

Search

| Advanced Search| Site Map| Home